The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases
- 15 December 2007
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 62 (12) , 1371-1379
- https://doi.org/10.1016/j.biopsych.2007.04.040
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Extended-release venlafaxine in relapse prevention for patients with major depressive disorderJournal of Psychiatric Research, 2004
- A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive DisorderAmerican Journal of Psychiatry, 2004
- Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major DepressionThe Journal of Clinical Psychiatry, 2004
- Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind StudyJournal of Clinical Psychopharmacology, 2001
- Prophylactic effect of citalopram in unipolar, recurrent depressionThe British Journal of Psychiatry, 2001
- Sertraline Versus Paroxetine in Major Depression: Clinical Outcome After Six Months of Continuous TherapyJournal of Clinical Psychopharmacology, 2000
- Multiple Recurrences of Major Depressive DisorderAmerican Journal of Psychiatry, 2000
- Mirtazapine versus amitriptyline in the long-term treatment of depressionInternational Clinical Psychopharmacology, 1998
- A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depressionInternational Clinical Psychopharmacology, 1993
- Three-Year Outcomes for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1990